Pricing Log in Create free account

Creative Medical Technology Holdings, Inc. (CELZ) vs Longeveron Inc. (LGVN)

Creative Medical Technology Holdings, Inc. and Longeveron Inc. are both Biotechnology companies. Creative Medical Technology Holdings, Inc. and Longeveron Inc. are of similar size ($5.1M and $5.1M). Longeveron Inc. grew revenue faster over the last twelve months: −42.7% against −79.4%. Creative Medical Technology Holdings, Inc. has the higher net margin (0.00% vs −1,977.6%) and the higher return on invested capital (0.00% vs −4,549.0%). Across the 18 metrics below, Creative Medical Technology Holdings, Inc. leads on 11 and Longeveron Inc. on 7.

Valuation

Metric CELZ LGVN Biotechnology median
P/E n/m n/m 8.58
P/S 165.49 4.20 10.29
P/B 0.32 0.48 2.29
Price to free cash flow n/m n/m 21.93
EV/EBITDA 0.96 0.19 0.67
EV/Sales (347.51) (3.63) 9.89
Earnings yield (272.37%) (622.64%) (31.56%)
Free cash flow yield (398.93%) (417.71%) (23.42%)

Profitability

Metric CELZ LGVN Biotechnology median
Gross margin 61.18% 69.76% 65.77%
Operating margin 0.00% (1,992.84%) 0.00%
Net margin 0.00% (1,977.59%) 0.00%
Free cash flow margin 0.00% (1,755.69%) 0.00%
Return on equity (77.91%) (203.61%) (54.09%)
Return on assets (73.30%) (145.64%) (47.78%)
Return on invested capital 0.00% (4,549.04%) 0.00%

Growth

Metric CELZ LGVN Biotechnology median
Revenue growth (TTM) (79.42%) (42.74%) 5.83%
EPS growth (last fiscal year) 32.08% 50.76% 29.36%
Revenue growth, 5-year CAGR (48.43%) (26.60%) 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CELZ LGVN Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 12.91 2.63 4.80
Net debt to EBITDA 1.20 0.20 0.97

Dividend

Metric CELZ LGVN Biotechnology median
Dividend yield — — 0.44%
Payout ratio — — —

Size

Metric CELZ LGVN Biotechnology median
Market cap 5.10m 5.07m 153.35m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack